首页> 外文期刊>European Journal of Pharmacology: An International Journal >Activation of p38 mitogen-activated protein kinase by formyl-methionyl-leucyl-phenylalanine in rat neutrophils.
【24h】

Activation of p38 mitogen-activated protein kinase by formyl-methionyl-leucyl-phenylalanine in rat neutrophils.

机译:甲酰基-甲硫酰基-亮氨酰-苯丙氨酸在大鼠中性粒细胞中激活p38丝裂原活化的蛋白激酶。

获取原文
获取原文并翻译 | 示例
           

摘要

The signaling pathways leading to p38 mitogen-activated protein kinase (MAPK) activation in formyl-methionyl-leucyl-phenylalanine (fMLP)-stimulated rat neutrophils were examined. Immunoblot analysis with antibodies against a phosphorylated form of p38 MAPK showed that fMLP-stimulated p38 MAPK activation was dependent on a pertussis toxin-sensitive G protein. Two phosphatidylinositol 3-kinase inhibitors, wortmannin and 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002), did not affect the p38 MAPK activation. Phosphorylation of p38 MAPK was concentration dependently attenuated by a tyrosine kinase inhibitor, genistein, and by a Ca(2+)-dependent protein kinase C inhibitor, 13-cyanoethyl-12-methyl-6,7,12,13-tetrahydroindolo[2,3-a]pyrrolo[3 , 4-c]carbazole-7-one (Go6976). However, the protein kinase C inhibitors with a broader spectrum, 2-[1-(3-dimethylaminopropyl)-5-methoxy-1H-indol-3-yl]-3-(1H-indol-3-y l)-maleimide (Go6983) and 2-[1-(3-dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl)-maleimi de (GF109203X), had no inhibitory effect. fMLP-stimulated p38 MAPK phosphorylation was also reduced in cells pretreated with a phospholipase C inhibitor, 1-[6-((17beta-3-methoxyestra-1,3, 5(10)-trien-17-yl)amino)hexyl]-1H-pyrrole-2,5-dione (U73122), or preloaded with an intracellular Ca(2+) chelator, 1, 2-bis-(o-aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid (BAPTA). We conclude that phosphorylation of p38 MAPK by fMLP stimulation in rat neutrophils is dependent on G(i/o) protein, nonreceptor tyrosine kinase, phospholipase C/Ca(2+), and probably Ca(2+)-dependent protein kinase C pathways.
机译:检查了在甲酰基-蛋氨酸-亮氨酰-苯丙氨酸(fMLP)刺激的大鼠中性粒细胞中导致p38丝裂原活化蛋白激酶(MAPK)激活的信号通路。用针对p38 MAPK磷酸化形式的抗体进行的免疫印迹分析表明,fMLP刺激的p38 MAPK激活依赖于百日咳毒素敏感的G蛋白。两种磷脂酰肌醇3-激酶抑制剂渥曼青霉素和2-(4-吗啉基)-8-苯基-4H-1-苯并吡喃-4-酮(LY294002)不会影响p38 MAPK的活化。 p38 MAPK的磷酸化被酪氨酸激酶抑制剂染料木黄酮和依赖Ca(2+)的蛋白激酶C抑制剂13-氰基乙基-12-甲基-6,7,12,13-tetrahydroindolo [2]浓度依赖性减弱。 ,3-a]吡咯并[3,4-c]咔唑-7-一(Go6976)。然而,具有更广谱的蛋白激酶C抑制剂2- [1-(3-二甲基氨基丙基)-5-甲氧基-1H-吲哚-3-基] -3-(1H-吲哚-3-基)-马来酰亚胺( Go6983)和2- [1-(3-二甲基氨基丙基)-1H-吲哚-3-基] -3-(1H-吲哚-3-基)-马来酰亚胺(GF109203X)没有抑制作用。在用磷脂酶C抑制剂1- [6-((17beta-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl]预处理的细胞中,fMLP刺激的p38 MAPK磷酸化也降低了。 -1H-吡咯-2,5-二酮(U73122),或预先装有细胞内Ca(2+)螯合剂,1、2-双-(邻氨基苯氧基)-乙烷-N,N,N',N'-四乙酸(BAPTA)。我们得出结论,在大鼠中性粒细胞中,由fMLP刺激引起的p38 MAPK磷酸化取决于G(i / o)蛋白,非受体酪氨酸激酶,磷脂酶C / Ca(2+),以及可能是Ca(2+)依赖性蛋白激酶C途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号